Oracle shares slide as investors refocus on dilution and spending risk after AI-driven results pop

Oracle Corporation (ORCL) is down 3.6% today. Here is some analysis on what might have caused this price movement.

Analysis: The drop looks tied to a post-earnings pullback as investors refocus on Oracle’s large 2026 funding and capex plans, which can pressure the stock through dilution and higher financing costs. Recent analyst note activity also appears mixed, with debate centered on margins and execution risk for the AI infrastructure buildout.

Details:

Oracle laid out a 2026 plan to raise about $45–$50 billion, including up to $20 billion via an at-the-market common stock program, which can weigh on shares when investors anticipate incremental supply.

In its fiscal Q3 2026 results materials, Oracle reiterated very elevated capital spending expectations (including $50 billion of capex for fiscal 2026), keeping focus on cash needs and payback timing.

The same Q3 release highlighted a sharp jump in remaining performance obligations tied largely to large AI contracts, but the market still has to judge how quickly backlog converts into profitable revenue.

Following the March earnings release, multiple firms adjusted price targets and commentary, with some emphasizing margin pressure and financing/dilution overhangs despite strong growth metrics.

Sources:

Oracle Investor Relations, U.S. SEC, Yahoo Finance, IFR

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$ORCL Insider Trading Activity

$ORCL insiders have traded $ORCL stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.

Here’s a breakdown of recent trading of $ORCL stock by insiders over the last 6 months:

CLAYTON M. MAGOUYRK (Chief Executive Officer) has made 0 purchases and 3 sales selling 60,000 shares for an estimated $14,542,978.
JEFFREY BERG has made 0 purchases and 4 sales selling 49,365 shares for an estimated $13,971,266.
MICHAEL D. SICILIA (President, Industries) sold 33,845 shares for an estimated $10,869,660
DOUGLAS A KEHRING (EVP, Principal Financial Offcr) sold 35,000 shares for an estimated $6,821,149
STUART LEVEY (EVP, Chief Legal Officer) sold 19,758 shares for an estimated $5,927,400
MARK HURA (Pres., Global Field Operations) sold 15,000 shares for an estimated $2,953,314
MARIA SMITH (EVP, Chief Accounting Officer) has made 0 purchases and 2 sales selling 10,000 shares for an estimated $2,803,122.
NAOMI O SELIGMAN has made 0 purchases and 2 sales selling 4,445 shares for an estimated $1,079,022.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$ORCL Hedge Fund Activity

We have seen 1,633 institutional investors add shares of $ORCL stock to their portfolio, and 2,106 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 35,884,353 shares (-72.7%) from their portfolio in Q4 2025, for an estimated $6,994,219,243
JPMORGAN CHASE & CO removed 8,349,915 shares (-16.8%) from their portfolio in Q4 2025, for an estimated $1,627,481,932
BLACKROCK, INC. added 8,132,507 shares (+5.8%) to their portfolio in Q4 2025, for an estimated $1,585,106,939
CAPITAL RESEARCH GLOBAL INVESTORS added 6,826,299 shares (+29.3%) to their portfolio in Q4 2025, for an estimated $1,330,513,938
VANGUARD GROUP INC added 5,841,584 shares (+3.5%) to their portfolio in Q4 2025, for an estimated $1,138,583,137
CAPITAL WORLD INVESTORS removed 5,269,003 shares (-76.7%) from their portfolio in Q4 2025, for an estimated $1,026,981,374
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 4,650,737 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $906,475,148

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$ORCL Government Contracts

We have seen $1,074,708,652 of award payments to $ORCL over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

EHRM WAVES K, L, M (VISN 23) AND N, O (VISN 15) DEPLOYMENTS: $345,933,136
IGF::OT::IGF TASK ORDER 36C10B18N0003 UNDER IDIQ CONTRACT 36C10B18D5000 FOR OPERATIONAL MANAGEMENT SERVICES...: $217,811,814
EHRM OPERATIONS: $112,624,045
FORMALLY RECOGNIZE THE CONTRACTORS CORPORATE NAME CHANGE FROM CERNER GOVERNMENT SERVICES INC. TO ORACLE HEA...: $103,827,947
EHRM LICENSES AND FEES: $97,806,309

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

$ORCL Congressional Stock Trading

Members of Congress have traded $ORCL stock 12 times in the past 6 months. Of those trades, 5 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $ORCL stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 6 times. They made 3 purchases worth up to $45,000 on 01/30, 11/18, 10/17 and 3 sales worth up to $45,000 on 02/24, 12/24, 12/19.
REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
SENATOR TOMMY TUBERVILLE sold up to $50,000 on 10/07.
REPRESENTATIVE CLEO FIELDS purchased up to $50,000 on 09/23.
REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$ORCL Analyst Ratings

Wall Street analysts have issued reports on $ORCL in the last several months. We have seen 13 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

Piper Sandler issued a "Overweight" rating on 02/03/2026
Jefferies issued a "Buy" rating on 01/05/2026
BMO Capital issued a "Outperform" rating on 12/11/2025
Bernstein issued a "Outperform" rating on 12/11/2025
Stifel issued a "Buy" rating on 12/11/2025
Deutsche Bank issued a "Buy" rating on 11/26/2025
Baird issued a "Outperform" rating on 11/18/2025

To track analyst ratings and price targets for $ORCL, check out Quiver Quantitative's $ORCL forecast page.

$ORCL Price Targets

Multiple analysts have issued price targets for $ORCL recently. We have seen 30 analysts offer price targets for $ORCL in the last 6 months, with a median target of $240.0.

Here are some recent targets:

Siti Panigrahi from Mizuho set a target price of $320.0 on 03/16/2026
John Difucci from Guggenheim set a target price of $400.0 on 03/13/2026
Tyler Radke from Citigroup set a target price of $320.0 on 03/12/2026
Raimo Lenschow from Barclays set a target price of $240.0 on 03/11/2026
Brad Reback from Stifel set a target price of $220.0 on 03/11/2026
Billy Fitzsimmons from Piper Sandler set a target price of $210.0 on 03/11/2026
Rishi Jaluria from RBC Capital set a target price of $160.0 on 03/11/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.